Rat lung cancer induced by melathion and estrogen

International Journal of Oncology

Volumn 33, Issue 3, 2008, Pages 603-611

  Echiburu Chau C ^a   Calaf, Gloria M ^a,b  

^a UNIVERSIDAD DE TARAPACÁ   (Chile)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Estrogen; Malathion; Organophosphorous pesticides; Rat lung cancer

Indexed keywords

CARCINOGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; MALATHION; ORGANOPHOSPHATE INSECTICIDE; RHO KINASE; SODIUM CHLORIDE; ESTROGEN; INSECTICIDE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CANCER RISK; CELL AGGREGATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EPITHELIUM HYPERPLASIA; INCIDENCE; LUNG CANCER; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG LESION; LUNG PARENCHYMA; LYMPHOCYTE; MALE; METAPLASIA; MOLECULAR BIOLOGY; MORPHOMETRICS; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG; LUNG TUMOR; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ESTRADIOL; ESTROGENS; FEMALE; IMMUNOHISTOCHEMISTRY; INSECTICIDES; LUNG; LUNG NEOPLASMS; MALATHION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ERBB-2; RHOA GTP-BINDING PROTEIN;

EID: 54849185900     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000046     Document Type: Article

References (64)

1. Alberg AJ and Samet JM: Epidemiology of lung cancer. Chest 123: S21-S49, 2003.
2. Damber LA and Larsson LG: Occupation and male lung cancer: a case-control study in northern Sweden. Br J Ind Med 44: 446-453, 1987.
3. Fenske RA, Lu C, Barr D and Needham L: Children's exposure to chlorpyrifos and parathion in an agricultural community in central Washington State. Environ Health Perspect 110: 549-553, 2002.
4. Koch D, Lu C, Fisker-Andersen J, Jolley L and Fenske RA: Temporal association of children's pesticide exposure and agricultural spraying: report of a longitudinal biological monitoring study. Environ Health Perspect 110: 829-833, 2002.
5. Wilhoit L, Davidson N, Supkoff D, et al: Pesticide use analysis and trends from 1991 to 1996. Environmental Protection Agency, Sacramento, CA, 1999.
6. Berkowitz GS, Obel J, Deych E, et al: Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort. Environ Health Perspect 111: 79-94, 2003.
7. CDC (Centers for Disease Control and Prevention): Second National Report on Human Exposure to Environmental Chemicals. NCEH Publication No. 03-0022. Atlanta, GA, 2003.
8. Lu C, Knutson DE, Fisker-Andersen J and Fenske RA: Biological monitoring survey of organophosphorus pesticide exposure among preschool children in the Seattle metropolitan area. Environ Health Perspect 109: 299-303, 2001.
9. Weisenburger DD: Human health effects of agrichemical use. Hum Pathol 24: 571-576, 1993.
10. Whyatt RM, Camann DE, Kinney PL, et al: Residential pesticide use during pregnancy among a cohort of urban minority women. Environ Health Perspect 110: 507-514, 2002.
11. Bretveld RW, Thomas CM, Scheepers PT, Zielhuis GA and Roeleveld N: Pesticide exposure: the hormonal function of the female reproductive system disrupted? Reprod Biol Endocrinol 4: 30, 2006.
12. Thomas L, Doyle LA and Edelman MJ: Lung cancer in women emerging differences in epidemiology, biology and therapy. Chest 128: 370-381, 2005.
13. Calaf G and Hei TK: Establishment of a radiation- and estrogen induced breast cancer. Carcinogenesis 21: 769-776, 2000.
14. Calaf G: Susceptibility of breast epithelial cells in vitro to hormones and drugs. Int J Oncol 28: 285-295, 2006.
15. Henderson BE, Ross RK, Pike MC and Casagrande JT: Endogenous hormones as a major factor in human cancer. Cancer Res 42: 3232-3239, 1982.
16. Taioli E and Wynder EL: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 86: 869-870, 1994.
17. Gretz JE, Anderson AO and Shaw S: Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol Rev 156: 11-24, 1997.
18. Bienenstock J, Johnston N and Perey DY: Bronchial lymphoid tissue: I. Morphologic characteristics. Lab Invest 28: 686-692, 1973.
19. Travis WD and Galvin JR: Non-neoplastic pulmonary lymphoid lesions. Thorax 56: 964-971, 2001.
20. Alimandi M, Romano A, Curia MC, et al: Cooperative signalling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10: 1813-1821, 1995.
21. Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL and Hung MC: c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res 54: 3260-3266, 1994.
22. Klapper LN, Kirschbaum MH, Sela M and Yarden Y: Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res 77: 25-79, 2000.
23. Graus-Porta D, Beerli RR, Daly JM and Haynes NE: ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16: 1647-1655, 1997.
24. Kaibuchi K, Kuroda S and Amano M: Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68: 459-486, 1999.
25. Michiels F and Collard JG: Rho-like GTPases: their role in cell adhesion and invasion. Biochem Soc Symp 65: 125-146, 1999.
26. National Cancer Institute: Bioassay of malathion for possible carcinogenicity. Technical report series No. 24. DHEW Publication No. (NIH) 78-824, 1978.
27. Institute of Animal Laboratory Resources: Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC, 1996.
28. Cabello G, Valenzuela M, Vilaxam A, Durán V, Rudolph I, Hrepic N and Calaf GM: A rat mammary tumor model induced by the organophosphorous pesticides parathion and malathion, possibly through acetylcholinesterase inhibition. Environ Health Perspect 109: 471-479, 2001.
29. Breuer RH, Pasic A, Smit EF et al: The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 11: 537-543, 2005.
30. Brambilla E, Travis WD, Colby TV, Corrin B and Shimosato Y: The new WHO classification of lung tumours. Eur Respir J 18: 1059-1068, 2001.
31. Colby TV, Wistuba II and Gazdar A: Precursors to pulmonary neoplasia. Adv Anat Pathol 5: 205-215, 1998.
32. Wilbur A and Franklin MD: Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia. Chest 117: 80-89, 2000.
33. Dinsdale D, Verschoyle RD and Ingham JE: Ultrastructural changes in rat Clara cells induced by a single dose of O, S, S-trimethylphosphorodithioate. Arch Toxicol 56: 59-65, 1984.
34. Frost JK, Ball WC Jr, Levin ML, et al: Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure. J Occup Med 28: 692-703, 1986.
35. Venmans BJ, van Boxem TJ, Smit EF, Postmus PE and Sutedja TG: Outcome of bronchial carcinoma in situ. Chest 117: 1572-1576, 2000.
36. Swigris JJ, Berry GJ, Raffin TA and Kuschner WG: Lymphoid interstitial pneumonia: a narrative review. Chest 122: 2150-2164, 2002.
37. Pabst R and Gehrke I: Is the bronchus associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am J Respir Cell Mol Biol 3: 131-135, 1990.
38. Tango M, Suzuki E, Gejyo F and Ushiki T: The presence of specialized epithelial cells on the bronchus-associated lymphoid tissue (BALT) in the mouse. Arch Histol Cytol 63: 81-89, 2000.
39. Iwata M and Sato A: Morphological and immunohistochemical studies of the lungs and bronchus-associated lymphoid tissue in a rat model of chronic pulmonary infection with pseudomonas aeruginosa. Infect Immun 59: 1514-1520, 1991.
40. Sminia T, van der Brugge-Gamelkoorn GJ and Jeurissen SH: Structure and function of bronchus-associated lymphoid tissue (iBALT). Crit Rev Immunol 9: 119-150, 1989.
41. Koss MN: Pulmonary lymphoid disorders. Semin Diagn Pathol 12: 158-171, 1995.
42. Moyron-Quiroz JE, Rancel-Moreno J, Kusser K, et al: Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 10: 927-934, 2004.
43. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M and Randall TD: Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 116: 3183-3194, 2006.
44. Parsonnet J: Molecular mechanisms for inflammation-promoted pathogenesis of cancer - The Sixteen International Symposium of the Sapporo Cancer Seminar. Cancer Res 57: 3620-3624, 1997.
45. Brown LM, Blair A, Gibson R, Everett GD, Cantor KP, Schuman LM, Burmeister LF, van Lier SF and Dick F: Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res 50: 6585-6591, 1990.
46. Cantor KP, Blair A, Everett G, et al: Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota. Cancer Res 52: 2447-2455, 1992.
47. McDuffie HH, Pahwa P, MacLaughlin JR, et al: Non-Hodgkin's lymphoma and specific pesticide exposures in men: cross-Canada study of pesticides and health. Cancer Epidemiol Biomarkers Prev 10: 1155-1153, 2001.
48. Aleric I, Tentor D and Jakic-Razumovic J: Multiple lung infiltrates. Respiration 71: 101-103, 2004.
49. Ahmed S, Siddiqui AK and Rai KR: Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma. Cancer Invest 20: 1059-1068, 2002.
50. Hazleton LW and Holland EG: Toxicity of malathon: summary of mammalian investigations. AMA Arch Ind Hgy Occup Med 8: 399-405, 1953.
51. Okey AB: Dimethylbenzanthracene-induced mammary tumors in rats: inhibition by DDT. Life Sci I 11: 833-843, 1972.
52. Xu J and Li Q: Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 17: 1681-1692, 2003.
53. Stabile LP, Davis AL, Gubish CT, et al: Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 62: 2141-2150, 2002.
54. Adami HO, Persson I, Hoover R, Schairer C and Bergkvist L: Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 44: 833-839, 1989.
55. Saracci R and Boffetta P: Interactions of tobacco smoking and other causes of lung cancer. In: Epidemiology of Lung Cancer: Lung Cancer in Health and Desease. Samet JM (ed.) Marcel Dekker, New York, NY, pp 465-493, 1994.
56. Hershberger PA, Vasquez AC, Kanterewicz BL and Siegfried JM and Nichols M: Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 65: 1598-1605, 2005.
57. Calaf G and Hei TK: Oncoprotein expressions in human breast epithelial cells transformed by high-LET radiation. Int J Radiat Biol 77: 31-40, 2001.
58. Tateishi M, Ishida T, Kohdono S, Hamatake M, Fukuyama Y and Sugimachi K: Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma. Surg Oncol 3: 109-113, 1994.
59. Onn A, Correa A, Gilcrease M, et al: Overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 10: 136-143, 2004.
60. Brabender J, Danenberg K, Metzger R, et al: Epidermal growth factor receptor and her2-neu mrna expression in non-small cell lung cancer is correlated with survival. Clin Cancer Res 7: 1850-1855, 2001.
61. Del Peso L, Hernandez-Alcoceba R, Embade N, Carnero A, Esteve P, Paje C and Lacal JC: Rho proteins induce metastático properties in vivo. Oncogene 15: 3057-3067, 1997.
62. Fort P: Small GTPases of the Rho family and cell transformation. Prog Mol Subcell Biol 22: 159-181, 1999.
63. Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL and Der CJ: Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene 17: 1415-1438, 1999.
64. Varker KA, Phelps SH, King MM and Williams CL: The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies. Int J Oncol 22: 671-681, 2003.